ABVC BioPharma, Inc. (ABVC)

0.84 -0.06 (-6.48%) USD  |  NASDAQ  |  Aug 24, 16:00
0.8444 0.00 (0.00%) After-Hours: 20:00
More

ABVC BioPharma Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ABVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2021. Start Trial.
Date Value
May 24, 2023 --
January 18, 2023 --
December 31, 2022 --
December 20, 2022 --
November 16, 2022 --
September 16, 2022 --
Date Value
June 17, 2022 --
June 07, 2022 --
December 10, 2021 --
August 27, 2021 --
January 26, 2021 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
MiMedx Group, Inc. Upgrade
Abbott Laboratories Upgrade
AngioDynamics, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade